Mark Strobeck
President and CEO at Rockwell Medical, Inc. (RMTI) since July 2022
Mark Strobeck has filed 21 insider reports with the SEC since July 2022, as president and CEO at Rockwell Medical, Inc. (RMTI) and director at Windtree Therapeutics Inc /de/ (WINT). Mark Strobeck made no open-market purchases or sales in the last 12 months. The latest filing, on October 1, 2026, is a Form 144 notice: Mark Strobeck plans to sell 1,000 RMTI shares (~$8,400).
Planned sale (Form 144)
- Mark Strobeck plans to sell 1,000 RMTI shares (~$8,400), around Oct 1, 2026. Notice filed Oct 1, 2026.
A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.
- Filings
- 21
- Companies
- 2
- Bought on market
- None
- Sold on market
- $39.5K
Companies where Mark Strobeck is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| President and CEOsince July 2022 | 62,349 | $39.5K | $6.10 | Oct 1, 2026 | |||
| Directorsince June 2023 | 2,300 | Aug 25, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Oct 1, 2026~$8,400RMTIMark Strobeck plans to sell 1,000 shares (~$8,400)Form 144Planned sale10b5-1 plan
- Jul 1, 2026RMTIPresident and CEO Strobeck Mark was granted 30,000 shares, increasing direct ownership by 93% to 62,349 unitsForm 4Grant or award
- May 20, 2025RMTIAmendment: SEC Form 4 filed by Strobeck MarkForm 4Grant or award
- Mar 14, 2026RMTIPresident and CEO Strobeck Mark covered exercise/tax liability with 7,333 shares, decreasing direct ownership by 2% to 323,493 unitsForm 4Shares withheld for taxes or exercise price
- Oct 1, 2025-$8,242RMTIPresident and CEO Strobeck Mark sold $8,242 worth of shares (6,926 units at $1.19), decreasing direct ownership by 2% to 330,826 unitsForm 4Open-market sale10b5-1 plan
- Jul 1, 2025-$5,679RMTIAmendment: President and CEO Strobeck Mark sold $5,679 worth of shares (6,926 units at $0.82), decreasing direct ownership by 2% to 337,752 unitsForm 4Open-market sale10b5-1 plan
- Jul 1, 2025-$5,679RMTIPresident and CEO Strobeck Mark sold $5,679 worth of shares (6,926 units at $0.82), decreasing direct ownership by 2% to 337,752 unitsForm 4Open-market sale10b5-1 plan
- May 20, 2025RMTIPresident and CEO Strobeck Mark was granted 220,000 shares, increasing direct ownership by 176% to 344,678 unitsForm 4Grant or award
- Apr 1, 2025-$7,480RMTIPresident and CEO Strobeck Mark sold $7,480 worth of shares (6,926 units at $1.08), decreasing direct ownership by 5% to 124,678 unitsForm 4Open-market sale10b5-1 plan
- Apr 1, 2025~$7,263RMTIMark Strobeck plans to sell 6,926 shares (~$7,263)Form 144Planned sale10b5-1 plan
- Mar 17, 2025RMTIPresident and CEO Strobeck Mark covered exercise/tax liability with 13,434 shares, decreasing direct ownership by 9% to 131,604 unitsForm 4Shares withheld for taxes or exercise price
- Jan 2, 2025-$4,445RMTIPresident and CEO Strobeck Mark sold $4,445 worth of shares (2,163 units at $2.06), decreasing direct ownership by 1% to 145,038 unitsForm 4Open-market sale10b5-1 plan
- Jan 2, 2025~$4,445RMTIMark Strobeck plans to sell 2,163 shares (~$4,445)Form 144Planned sale10b5-1 plan
- Oct 1, 2024-$7,971RMTIPresident and CEO Strobeck Mark sold $7,971 worth of shares (2,163 units at $3.69), decreasing direct ownership by 1% to 147,201 unitsForm 4Open-market sale10b5-1 plan
- Mar 17, 2024RMTIStrobeck Mark covered exercise/tax liability with 6,101 shares, decreasing direct ownership by 4% to 149,364 unitsForm 4Shares withheld for taxes or exercise price
- Mar 14, 2024RMTIStrobeck Mark was granted 100,000 shares, increasing direct ownership by 180% to 155,465 unitsForm 4Grant or award
- Aug 23, 2023WINTSEC Form 4: Strobeck Mark was granted 2,300 sharesForm 4Grant or award
- Jun 22, 2023WINTMark Strobeck became an insiderForm 3New insider
- Mar 17, 2023RMTISEC Form 4 filed by Strobeck MarkForm 4Grant or award
- Jul 1, 2022RMTISEC Form 4 filed by Strobeck MarkForm 4Grant or award
- Jul 1, 2022RMTIMark Strobeck became an insiderForm 3New insider
Compare Mark Strobeck with
- Mark Strobeck vs Joseph H Dawson1 shared
- Mark Strobeck vs Allen Nissenson1 shared
- Mark Strobeck vs Joan Lau1 shared
- Mark Strobeck vs Robert S Radie1 shared
- Mark Strobeck vs John G Cooper1 shared
- Mark Strobeck vs Timothy Chole1 shared
Other insiders at the same companies
- Joseph H DawsonRMTI
- Allen NissensonRMTI
- Joan LauRMTI
- Robert S RadieRMTI
- John G CooperRMTI
- Timothy CholeRMTI
- Heather HunterRMTI
- Megan C. TimminsRMTI
- Jesse NeriRMTI
- Andrew Albert KucharchukWINT
- Mark H RavichRMTI
- Andrea Heslin SmileyRMTI
- Irrevocable Larson Family Investment TrustRMTI
- Leanne KellyWINT
Questions about Mark Strobeck
- What is Mark Strobeck's role at Rockwell Medical, Inc.?
- Mark Strobeck reports to the SEC as president and CEO at Rockwell Medical, Inc. (RMTI), according to the latest filing on October 1, 2026. Mark Strobeck has also filed as director at Windtree Therapeutics Inc /de/ (WINT).
- How many shares does Mark Strobeck own?
- After the latest filing that states it, Mark Strobeck directly owned 62,349 shares of Rockwell Medical, Inc. (RMTI) and 2,300 shares of Windtree Therapeutics Inc /de/ (WINT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Strobeck bought or sold stock recently?
- The most recent open-market sale was on October 1, 2025: sold 6,926 shares of Rockwell Medical, Inc. (RMTI) for $8,242 at an average of $1.19.
- How do I get alerts when Mark Strobeck files?
- Follow Mark Strobeck on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Strobeck filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Mark Strobeck (SEC CIK 0001599219). Totals count each trade once, skipping amendments whose original is on file, from Jul 5, 2022 on. View on SEC EDGAR